We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

20 hedge funds and large institutions have $1.46M invested in AIM ImmunoTech in 2020 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

376% more capital invested

Capital invested by funds: $307K → $1.46M (+$1.15M)

275% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 4

122% more funds holding

Funds holding: 9 → 20 (+11)

Holders
20
Holders Change
+11
Holders Change %
+122.22%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
2
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$305K
2
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$201K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$136K
4
Jane Street
Jane Street
New York
+$44.1K
5
Morgan Stanley
Morgan Stanley
New York
+$28.4K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$288K
2
Renaissance Technologies
Renaissance Technologies
New York
-$9K
3
Deutsche Bank
Deutsche Bank
Germany
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
1
Millennium Management
New York
$498K +$305K +1,946 New
Hudson Bay Capital Management
2
Hudson Bay Capital Management
Connecticut
$327K +$201K +1,279 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$222K +$136K +867 New
Jane Street
4
Jane Street
New York
$72K +$44.1K +281 New
Osaic Holdings
5
Osaic Holdings
Arizona
$61K +$37.3K +238 New
Bank of America
6
Bank of America
North Carolina
$50K +$25.4K +162 +506%
Morgan Stanley
7
Morgan Stanley
New York
$46K +$28.4K +181 +18,100%
Goldman Sachs
8
Goldman Sachs
New York
$38K +$23.2K +148 New
ASN
9
Advisory Services Network
Georgia
$32K +$19.6K +125 New
TCM
10
Traynor Capital Management
Pennsylvania
$30K +$18.5K +118 New
BlackRock
11
BlackRock
New York
$27K – – –
HF
12
HRT Financial
New York
$25K +$15.7K +100 New
Victory Capital Management
13
Victory Capital Management
Texas
$22K +$13.6K +87 New
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$5K +$3.14K +20 New
Wells Fargo
15
Wells Fargo
California
$3K +$1.73K +11 New
S
16
SignatureFD
Georgia
$1K +$784 +5 New
VNA
17
Valley National Advisers
Pennsylvania
$1K +$784 +5 New
APA
18
American Portfolios Advisors
New York
$584 – – –
SM
19
Sabby Management
Florida
– -$288K -5,293 Closed
Renaissance Technologies
20
Renaissance Technologies
New York
– -$9K -173 Closed
Deutsche Bank
21
Deutsche Bank
Germany
– -$2K -44 Closed
Citigroup
22
Citigroup
New York
– +$157 +1 New

AIM Hedge Fund Activity: Q1 2020 in Review

20 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q1 2020, worth a combined $1.46M — up 376% from $307K a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new AIM positions and 4 closed out — a net gain of 11 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $305K. The largest seller was Sabby Management, exiting entirely with an estimated $288K sold.

  • 20 institutional investors held AIM ImmunoTech (AIM) as of Q1 2020, up from 9 in Q4 2019.
  • Funds reported $1.46M of AIM ImmunoTech stock for Q1 2020, up 376% quarter-over-quarter.
  • 15 funds opened new AIM ImmunoTech positions in Q1 2020 and 4 closed out, a net change of +11 holders.
  • The largest AIM ImmunoTech buyer in Q1 2020 was Millennium Management, an estimated $305K added.
  • The largest AIM ImmunoTech seller in Q1 2020 was Sabby Management, an estimated $288K sold.

Based on aggregated 13F filings for Q1 2020.